Global Endoscopic Vessel Harvesting Market Size By Type (Disposable, Reusable), By Application (Coronary Artery Disease, Peripheral Artery Disease), By Region, And Segment Forecasts, 2023 to 2032

The Global Endoscopic Vessel Harvesting (EVH) Market was valued at USD 430 million in 2023 and is projected to reach USD 782 million by 2031, growing at a CAGR of 7.6% during the forecast period (2023–2031). The market's growth is driven by the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive surgical techniques, and technological advancements in endoscopic tools. EVH systems enable the less invasive removal of saphenous veins or radial arteries for coronary artery bypass grafting (CABG), reducing patient trauma and improving recovery outcomes.

Drivers:

1. Rising Prevalence of Cardiovascular Diseases:

The increasing global incidence of coronary artery diseases has amplified the demand for coronary artery bypass surgeries, in turn fueling the need for endoscopic vessel harvesting systems that offer superior cosmetic outcomes and fewer complications compared to traditional methods.

2. Shift Toward Minimally Invasive Surgeries:

Minimally invasive procedures are increasingly preferred due to their benefits, including reduced pain, shorter hospital stays, and faster recovery. EVH fits this trend perfectly, especially in high-volume cardiac centers.

3. Technological Advancements in EVH Devices:

Improvements in imaging clarity, instrument precision, and ergonomic design of EVH systems are encouraging greater adoption by cardiovascular surgeons and healthcare institutions globally.

Restraints:

1. High Cost of Equipment and Training:

The initial investment in EVH systems and the associated training for surgical staff are significant. This acts as a barrier, especially for smaller hospitals in developing regions.

2. Steep Learning Curve and Lack of Skilled Personnel:

EVH requires specific technical skills and experience, which may not be readily available in all healthcare settings, limiting market penetration.

Opportunity:

1. Growing Demand in Emerging Economies:

Rising healthcare infrastructure investments and increasing awareness in regions like Asia-Pacific and Latin America present a lucrative opportunity for EVH market expansion.

2. Integration with Robotic and AI-Assisted Surgery:

The convergence of EVH technologies with robotic-assisted surgical platforms offers improved precision, reduced variability, and better patient outcomes—creating new growth frontiers.

Market by System Type Insights:

Based on system type, the Closed EVH Systems segment held the largest market share in 2023. Closed systems offer better visualization, reduced risk of infection, and more consistent outcomes compared to open EVH systems. These systems are especially favored in high-risk cardiac patients and are expected to see continued demand.

Market by End-Use Insights:

Hospitals emerged as the largest end-use segment in 2023, accounting for more than 60% of the market share. High volumes of cardiac procedures, availability of trained surgeons, and investments in advanced medical technologies make hospitals the primary users of EVH systems. Ambulatory Surgical Centers (ASCs) are anticipated to grow at the fastest pace due to their cost-effectiveness and increasing capacity for complex procedures.

Market by Regional Insights:

North America dominated the EVH market in 2023, driven by high prevalence of cardiovascular diseases, favorable reimbursement policies, and early adoption of advanced surgical technologies. Asia-Pacific is projected to register the fastest growth during the forecast period, supported by improving healthcare infrastructure, rising medical tourism, and increasing awareness of minimally invasive surgery benefits.

Competitive Scenario:

Key players in the global EVH market include Getinge AB, Terumo Corporation, Stryker Corporation, Med Europe S.r.l., LivaNova PLC, KARL STORZ SE & Co. KG, and Olympus Corporation. These companies focus on R&D, strategic acquisitions, and product innovation to gain competitive advantage.

In 2023, Getinge AB introduced an advanced EVH system with enhanced ergonomics and visualization to reduce procedural time.

In 2024, Terumo Corporation expanded its endoscopic surgical tools portfolio through the acquisition of a minimally invasive device manufacturer.

Scope of Work – Global Endoscopic Vessel Harvesting Market

Key Market Developments:

2023: Getinge launched a next-generation EVH system with 3D visualization and improved hemostasis features.

2024: Stryker Corporation partnered with AI developers to enhance intraoperative decision-making in EVH procedures.

2025: KARL STORZ expanded its EVH training programs globally to support upskilling of cardiovascular surgeons.

FAQs:

1. What is the current market size of the Global Endoscopic Vessel Harvesting Market?

The market was valued at USD 430 million in 2023.

2. What is the major growth driver of the Global Endoscopic Vessel Harvesting Market?

The major growth driver is the rising number of coronary artery bypass surgeries and the preference for minimally invasive procedures.

3. Which is the largest region during the forecast period in the Global Endoscopic Vessel Harvesting Market?

North America is the largest region due to advanced healthcare infrastructure and high procedure volumes.

4. Which segment accounted for the largest market share in Global Endoscopic Vessel Harvesting Market?

The Closed EVH Systems segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Endoscopic Vessel Harvesting Market?

Key players include Getinge AB, Terumo Corporation, Stryker Corporation, KARL STORZ SE & Co. KG, and Olympus Corporation.